Plerixafor solution

(別名: AMD 3100 solution; JM3100 solution; SID791 solution)
103 Cited Publications
カスタマーレビュー

Based on 103 publication(s) in Google Scholar

Plerixafor solution (AMD 3100 solution; JM3100 solution; SID791 solution) is a CXCR4 antagonist and a CXCR7 allosteric agonist; Plerixafor solution disrupts stem cell retention in the bone marrow by blocking the SDF-1α/CXCL12‑CXCR4 signaling pathway and inhibiting chemokine-mediated receptor internalization, mobilizing peripheral blood leukocytes, neutrophils, endothelial progenitor cells, and B cells; Plerixafor solution alleviates Silicon dioxide (HY-W019831)-induced pulmonary inflammation and fibrosis, inhibits corneal neovascularization and CXCL12-induced cell migration, and simultaneously suppresses ischemia-induced inflammatory responses, reduces blood-brain barrier permeability, attenuates cerebral edema, and reduces infarct volume. Plerixafor solution can be used in research related to liver fibrosis, silicosis, colorectal cancer, and ischemic stroke.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

  • CAS 番号: 110078-46-1
  • 分子式: C28H54N8
  • 分子量:502.78
  • 保管条件:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • 生物活性
  • 化学情報
  • プロトコル
  • 純度とドキュメンテーション
  • 参考文献
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

お問い合わせ 在庫あり

Other size
お問い合わせ
Please select quantity
Amount: USD 0.00